SLC12A3 and pseudohypoaldosteronism type 2: Familial hyperkalemic hypertension (FHHt, also known as Pseudohypoaldosteronism type II or Gordon Syndrome) comprises the clinical manifestation of overactivated Na+-Cl−-Cotransporter (NCC) in the distal convoluted tubule (DCT) of the renal nephron.